Main menu:
Projects
THE TOPIC
THE CASMedCHEM strategy
Molecular descriptors
2D and 3D QSAR models
Blood-brain-barrier (BBB) passage
In many cases a drug molecule that is of potential benefit in treating brain pathologies must first penetrate the BBB. Surmounting this barriers is therefore a crucial factor in developing effective drug therapies for cerebral disorders. One of the approaches used in developing drugs that can surmount the BBB is based on the structural variation of drug molecules with the aim of decreasing their HB properties.